Thoughts on Healthcare Markets and Technology

Thoughts on Healthcare Markets and Technology

Critical Healthcare Legal Battles: Industry-Shaping Cases to Watch

Trey Rawles's avatar
Trey Rawles
Nov 02, 2024
∙ Paid
Share

340B Program Litigation

Major Pharmaceutical Cases

Two landmark cases in federal courts are testing manufacturer restrictions on 340B pricing:

  • District of New Jersey case challenging single-pharmacy restrictions

  • District of DC case examining HHS enforcement authority

Combined impact: Over $4.5B in annual drug discounts at stake

Core issue: Balance between manufacturer rights and program integrity

Medicare Advantage Risk Adjustment

Leading Cases Testing FCA Liability

Two groundbreaking False Claims Act cases in federal courts:

  • Northern California case alleging $1B+ in risk adjustment violations

  • Tennessee case testing new DOJ theories on MA coding practices

Focus: Face-to-face encounter requirements

Industry impact: Will define standards for retrospective reviews

Hospital Payment Reform

Site-Neutral Payment Challenge

Major hospital association lawsuit pending Supreme Court review:

  • $800M+ annual reimbursement impact

  • Testing CMS authority on payment equalization

  • Implications for outpatient facility strategy

  • Potential to reshape hospital expansion planning

Healthcare Antitrust Enforcement

Hospital Merger Challenge

Major Western U.S. case examining:

  • $1.2B regional hospital transaction

  • Novel cross-market effect theories

  • First test of new merger guidelines

  • Preliminary injunction pending

Digital Health Vertical Integration

Significant case examining:

  • Healthcare technology acquisition

  • Data access implications

  • Competitive effects in digital health

  • Consent decree negotiations ongoing

Employment and Labor Law

Criminal Non-Compete Case

Precedent-setting prosecution:

  • First criminal case on healthcare labor allocation

  • Testing DOJ's non-compete enforcement approach

  • Implications for physician contracts

  • Trial scheduled Q3 2024

Key Timeline

Q2 2024:

  • MA risk adjustment trial

  • Hospital merger preliminary injunction

Q3 2024:

  • 340B manufacturer appeal

  • Criminal non-compete trial

Q4 2024:

  • Site-neutral payment Supreme Court decision (if accepted)

Industry Impact Areas

These cases will redefine:

1. Drug Pricing Models

- Contract pharmacy networks

- Manufacturer obligations

- Safety-net provider access

2. Medicare Advantage Operations

- Risk adjustment practices

- Documentation requirements

- Audit protocols

3. Provider Strategy

- Facility expansion

- Payment models

- Market consolidation

4. Employment Practices

- Non-compete agreements

- Labor market competition

- Physician contracts

5. Data Management

- Security requirements

- Breach liability

- Insurance coverage

Strategic Considerations

Organizations should prepare for:

- Revised 340B compliance programs

- Enhanced risk adjustment documentation

- Updated merger analysis frameworks

- Modified employment agreements

- Strengthened data security measures

Specific case details…

Keep reading with a 7-day free trial

Subscribe to Thoughts on Healthcare Markets and Technology to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Trey Rawles
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture